$137.92
1.36% day before yesterday
NYSE, Jan 02, 10:00 pm CET

Agilent Technologies Stock price

$137.95
-10.86 7.30% 1M
+17.29 14.33% 6M
+1.88 1.38% YTD
+4.52 3.39% 1Y
-11.70 7.82% 3Y
+19.31 16.28% 5Y
+97.26 239.03% 10Y
+114.14 479.50% 20Y
NYSE, Closing price Fri, Jan 02 2026
+1.88 1.38%

New AI Insights on Agilent Technologies Insights AI Insights on Agilent Technologies

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$39.1b
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
30.2 | 22.8
P/S
5.6 | 5.2
EV/Sales
- | -
EV/FCF
-
P/B
-
Dividends
DPS
$0.99
Yield 1Y | 5Y
0.7% | 0.7%
Growth 1Y | 5Y
5.1% | 6.6%
Payout 1Y | 3Y
21.7% | 21.5%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$6.9b | $7.5b
EBITDA
- | $2.2b
EBIT
$1.5b | $2.0b
Net Income
$1.3b | -
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
6.7% | 8.0%
EBITDA
- | -
EBIT
-5.5% | 33.0%
Net Income
1.1% | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
52.8%
EBITDA
- | 29.4%
EBIT
21.3%
Net
18.8% | -
Free Cash Flow
-
Financial Health
Equity Ratio
-
Return on Equity
-
ROCE
-
ROIC
-
Debt/Equity
-
More
EPS
$4.6
FCF per Share
-
Short interest
1.3%
Employees
18k
Rev per Employee
$390.0k
Show more

Is Agilent Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Agilent Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

16x Buy
62%
10x Hold
38%

Analyst Opinions

26 Analysts have issued a Agilent Technologies forecast:

Buy
62%
Hold
38%

Financial data from Agilent Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '25
+/-
%
6,948 6,948
7% 7%
100%
- Direct Costs 3,283 3,283
11% 11%
47%
3,665 3,665
3% 3%
53%
- Selling and Administrative Expenses 1,660 1,660
9% 9%
24%
- Research and Development Expense 452 452
1% 1%
7%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,478 1,478
5% 5%
21%
Net Profit 1,303 1,303
1% 1%
19%

In millions USD.

Don't miss a Thing! We will send you all news about Agilent Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilent Technologies Stock News

Positive
Seeking Alpha
10 days ago
Bloomberg's 2026 Dividend Focus list highlights 14 ‘safer' stocks with free cash flow yields exceeding dividend yields, signaling potential buy opportunities. Top projected net gainers for 2026 include Marvell Technology (MRVL), Nike (NKE), and PT Telekom Indonesia (TLK), with analyst-estimated gains up to 37.98%. Four ‘IDEAL' stocks—Aviva, Sodexo, Danske Bank, and Western Midstream—offer divid...
Neutral
Business Wire
18 days ago
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will present at the 44th Annual J.P. Morgan Healthcare Conference at 9 to 9:40 a.m. PST on Tuesday, Jan. 13, 2026. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations websi...
Neutral
Seeking Alpha
30 days ago
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
More Agilent Technologies News

Company Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Head office United States
CEO Padraig Mcdonnell
Employees 17,900
Founded 1999
Website www.agilent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today